Funding for this research was provided by:
Massachusetts General Hospital (Steve and Deborah Gorlin MGH Research Scholar Award)
Received: 3 May 2017
Accepted: 13 April 2018
First Online: 11 May 2018
Ethics approval and consent to participate
: The Institutional Review Board of the organizing hospital (Partners HealthCare, Protocol number: 2016P000935) approved the study. The Partners Human Research Committee determined the project met the criteria for Institutional Review Board exemption because the research was limited to the use of survey data, was not subject to FDA regulations, and there was no more than minimal risk to study subjects. Completion of the survey was considered implied consent of participation. All data used were strictly anonymized; only a research coordinator had access to the file linking responses to identifiers.
: KA serves on an advisory board for GSK; EGC serves as an expert witness in two ongoing law cases regarding the nature, extent and consequences of financial relationships between doctors and drug companies. The remaining authors have nothing to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.